NONCLINICAL TOXICOLOGY PROFILE OF ALG-055009, A NOVEL AND POTENT THYROID HORMONE RECEPTOR &amp;BETA; AGONIST, FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

Rezdiffra (resmetirom) - Madrigal Pharma

ALG-055009 - Aligos Therap

https://journals.lww.com/hep/fulltext/2024/10001/the_liver_meeting__san_diego,_california,_nov.1.aspx

Dinah Misner1; Kusum Gupta2; Kha Le3; Doug Clark1; Xuan Luong1; Meenakshi Venkatraman1; David Smith1; Tse-I Lin1; Julian Symons2; Lawrence Blatt1; Sushmita Chanda1

Oct 15, 2024